May 2018


Handling the Unhappy Premium IOL Patient

An ounce of prevention is worth a pound of cure, says this surgeon.

No Capsular Support: Do ACIOLs Still Make Sense?

New alternatives have many surgeons shying away from ACIOLs —but there’s still a place for them.

Is a Private Equity Deal Right for You? (Pt 2)

Surgeons and business experts answer ophthalmologists’ main questions. (Part two of two.)

PCO: What’s Wrong With Doing a YAG?

A lot of effort is being devoted to avoiding PCO, but some surgeons say a YAG isn’t that bad.

Planning for the Best Outcomes

Do more than just hope for them with intelligent cataract surgery planning for post-refractive eyes.


Review News

Ophthalmic Product Development Insights

Technology Update

New High-Tech IOL Options in the Pipeline

Three revolutionary ideas may help to raise the bar for post-surgery refractive outcomes and patient satisfaction.

Retinal Insider

Digging Deeper Into Protocol U

The DRCR Network’s study of two treatments for diabetic macular edema revealed the pros and cons of the approaches.

Refractive/Cataract Rundown

Is LVC Possible In CVD Patients?

Long considered an absolute contraindication, collagen vascular disease may not always be a bar for carefully selected patients.

Glaucoma Management

Diagnosing Early Glaucoma: Pearls and Pitfalls

In our ongoing attempts to detect the disease at its earliest stages, new technologies are showing promise.

Product News

Research Review

Wills Eye Resident Case Series

May 2018 Wills Eye Resident Case Series

A middle-aged man with esophageal cancer presents with a presumed case of central serous chorioretinopathy.